FIGURE

Fig. 9

ID

ZDB-FIG-181002-12

Publication

Casar et al., 2018 - RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

Other Figures

All Figure Page

Back to All Figure Page

Fig. 9

PTPRκ is a tumor suppressor in melanoma. a Analysis of PTPRκ expression in normal skin (n = 7), benign nevi (n = 18) and cutaneous melanoma samples (n = 45) generated using an available gene dataset, accessed through the Oncomine® platform. ***p < 0.001 ****p < 0.0001 by Student's t-test. b Survival curves for melanoma patients depending on PTPRκ expression levels (obtained from GEO GSE65904). c View of naevi (2/28; arrowhead, middle panel) and melanoma (2/28; arrowhead bottom panel, points to a protruding eye with a retroorbital tumor.) by 52 weeks post fertilization in ptprκ nullizygous zebrafish expressing KDELr-HV12 as a transgene. Representative pictures were taken at 8 weeks post fertilization. d Kaplan–Meier plot of tumor development in ptprκ wild-type nacre animals compared to ptprk−/− nacre animals, injected with NRAS-G12D. ****p < 0.0001 by Mantel-Cox test. e Representative melanoma lesions (see arrowheads) in zebrafish with the indicated ptprκ genotype expressing NRAS-G12D as a transgene. See also Supplementary Fig. 8

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Commun.